4.5 Article

Accuracy of Pulse Oximetry for Long-Term Oxygen Therapy Assessment in Chronic Obstructive Pulmonary Disease

Journal

ANNALS OF THE AMERICAN THORACIC SOCIETY
Volume 20, Issue 11, Pages 1587-1594

Publisher

AMER THORACIC SOC
DOI: 10.1513/AnnalsATS.202209-837OC

Keywords

COPD; hypoxemia; pulse oximetry; oxygen

Ask authors/readers for more resources

This study evaluated the performance of SpO(2) compared to arterial blood gas analysis in detecting severe resting hypoxemia in patients with COPD. The results showed that using only SpO(2) as a measure of oxygenation had a high false negative rate, and it is recommended to use ABG analysis to evaluate oxygenation in these patients.
Rationale: Landmark studies of long-term oxygen therapy (LTOT) in patients with chronic obstructive pulmonary disease (COPD) used arterial oxygen pressure (PaO2) to define severe hypoxemia; however, oxygen saturation as measured by pulse oximetry (SpO(2)) is commonly used instead. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines recommend evaluation with arterial blood gas (ABG) analysis if SpO(2) is <= 92%. This recommendation has not been evaluated in stable outpatients with COPD undergoing testing for LTOT. Objectives: To evaluate the performance of SpO(2) compared with ABG analysis of PaO2 and arterial oxygen saturation (SaO(2)) to detect severe resting hypoxemia in patients with COPD. Methods: Retrospective analysis of paired SpO(2) and ABG values from stable outpatients with COPD who underwent LTOT assessment in a single center. We calculated false negatives (FNs) as an SpO(2)>88% or>89% in the presence of pulmonary hypertension with a PaO2 <= 55mmHg or <59mmHg in the presence of pulmonary hypertension. Test performance was assessed using receiver operating characteristic (ROC) analysis, intraclass correlation coefficient (ICC), test bias, precision, and accuracy root-mean-square (Arms). An adjusted multivariate analysis was used to evaluate factors affecting SpO(2) bias. Results: Of 518 patients, the prevalence of severe resting hypoxemia was 74 (14.3%), with 52 missed by SpO(2) (FN, 10%), including 13 (2.5%) with an SpO(2).92% (occult hypoxemia). FNs and occult hypoxemia in Black patients were 9% and 1.5%, respectively, and were 13% and 5%, respectively, among active smokers. The correlation between SpO(2) and SaO(2) was acceptable (ICC= 0.78; 95% confidence interval, 0.74-0.81); and the bias of SpO(2) was 0.45%, with a precision of 2.6 (24.65 to 15.55%) and Arms of 2.59. These measurements were similar in Black patients, but in active smokers, correlation was lower and bias showed greater overestimation of SpO(2). ROC analysis suggests that the optimal SpO(2) cutoff to warrant LTOT evaluation by ABG analysis is <94%. Conclusions: SpO(2) as the only measure of oxygenation carries a high FN rate in detecting severe resting hypoxemia in patients with COPD undergoing evaluation for LTOT. Reflex measurement of PaO2 by ABG analysis should be used as recommended by GOLD, ideally at a cutoff higher than an SpO2 <92%, especially in active smokers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available